| Serial Number | 79416047 |
| Word Mark | QUANTUM-WILD |
| Filing Date | Thursday, December 12, 2024 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Monday, June 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Providing medical information in the field of anticancer drugs; providing medical information on the efficacy, side effects, interactions or administration of anticancer drugs. |
| Goods and Services | Clinical studies and trials of anticancer drugs; providing information on clinical studies and trials of anticancer drugs. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 6, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 6, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | DAIICHI SANKYO COMPANY, LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Thursday, February 6, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, February 7, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 7, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, May 30, 2025 | ASSIGNED TO EXAMINER |
| Monday, June 2, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 3, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |